SPIRONOLACTONE — all Canadian products
16 DINs
9 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is SPIRONOLACTONE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02518821 | JAMP SPIRONOLACTONE | JAMP PHARMA CORPORATION | Tablet | Oral | SPIRONOLACTONE 25 MG | Marketed | |
| 02518848 | JAMP SPIRONOLACTONE | JAMP PHARMA CORPORATION | Tablet | Oral | SPIRONOLACTONE 100 MG | Marketed | |
| 02488159 | MINT-SPIRONOLACTONE | MINT PHARMACEUTICALS INC | Tablet | Oral | SPIRONOLACTONE 100 MG | Marketed | |
| 02488140 | MINT-SPIRONOLACTONE | MINT PHARMACEUTICALS INC | Tablet | Oral | SPIRONOLACTONE 25 MG | Marketed | |
| 02567229 | PRZ-SPIRONOLACTONE | PHARMARIS CANADA INC | Tablet | Oral | SPIRONOLACTONE 100 MG | Approved | |
| 00613223 | TEVA-SPIRONOLACTONE | TEVA CANADA LIMITED | Tablet | Oral | SPIRONOLACTONE 100 MG | Marketed | |
| 00613215 | TEVA-SPIRONOLACTONE | TEVA CANADA LIMITED | Tablet | Oral | SPIRONOLACTONE 25 MG | Marketed | |
| 00657182 | TEVA-SPIRONOLACTONE/HCTZ | TEVA CANADA LIMITED | Tablet | Oral | SPIRONOLACTONE 50 MG; HYDROCHLOROTHIAZIDE 50 MG | Marketed | |
| 00613231 | TEVA-SPIRONOLACTONE/HCTZ | TEVA CANADA LIMITED | Tablet | Oral | SPIRONOLACTONE 25 MG; HYDROCHLOROTHIAZIDE 25 MG | Marketed | |
| 00180408 | ALDACTAZIDE 25 | PFIZER CANADA ULC | Tablet | Oral | SPIRONOLACTONE 25 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Post Market | |
| 00594377 | ALDACTAZIDE 50 | PFIZER CANADA ULC | Tablet | Oral | SPIRONOLACTONE 50 MG; HYDROCHLOROTHIAZIDE 50 MG | Cancelled Post Market | |
| 00285455 | ALDACTONE 100 MG | PFIZER CANADA ULC | Tablet | Oral | SPIRONOLACTONE 100 MG | Cancelled Post Market | |
| 00028606 | ALDACTONE 25 MG | PFIZER CANADA ULC | Tablet | Oral | SPIRONOLACTONE 25 MG | Cancelled Post Market | |
| 00520802 | APO-SPIROZIDE TAB | APOTEX INC | Tablet | Oral | SPIRONOLACTONE 25 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Post Market | |
| 02347601 | NTP-SPIRONOLACTONE | NT PHARMA CANADA LTD | Tablet | Oral | SPIRONOLACTONE 25 MG | Cancelled Pre Market | |
| 02347628 | NTP-SPIRONOLACTONE | NT PHARMA CANADA LTD | Tablet | Oral | SPIRONOLACTONE 100 MG | Cancelled Pre Market |
Browse other molecules: